Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical phage cocktail plus clindamycin for acne vulgaris
IRCT20111224008507N7Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clindamycin in acne vulgaris (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Number of skin lesions, Number of inflammatory lesions and 2 more. Started Feb 2025; status: completed.
02
Drugs
clindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20111224008507N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111224008507N7.